Ignite Creation Date:
2025-12-24 @ 10:58 PM
Ignite Modification Date:
2025-12-31 @ 9:28 AM
Study NCT ID:
NCT01649869
Status:
COMPLETED
Last Update Posted:
2024-10-16
First Post:
2012-07-20
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Valganciclovir Therapy in Infants and Children With Congenital CMV Infection and Hearing Loss
Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Organization:
Organization Data
Organization:
Class:
NIH
Study ID:
11-0069
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
NIH
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None